Salahop, Naomie .
HRN: 11-41-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2023
CEFUROXIME 500MG (TAB)
01/14/2023
01/20/2023
ORAL
500
BID
LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Multiple Infections (tick All Sites)Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes